HJLI - ハンコック・ジャフィ・ラボラトリ―ズ (Hancock Jaffe Laboratories Inc.) ハンコック・ジャフィ・ラボラトリ―ズ

 HJLIのチャート


 HJLIの企業情報

symbol HJLI
会社名 Hancock Jaffe Laboratories Inc (ハンコック・ジャフィ・ラボラトリ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Hancock Jaffe Laboratories Inc. is a development stage medical device company. The Company is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease peripheral arterial and venous disease and end stage renal disease (ESRD). The Company is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV) is a bioprosthetic pig heart valve designed to function like a native heart valve and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic pig venous valve for patients with lower limb chronic venous insufficiency (CVI) which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.   ハンコック・ジャフィ・ラボラトリ―ズは米国の医療機器会社。冠状動脈、血管、末梢動脈など心臓に関する疾患を治療するために、生体組織溶液の開発・商業化に従事する。同社は移植可能な心血管バイオプロテ―ゼ・デバイスを開発・製造し、主な製品に「VenoValve」や「CreoGraft」などを含む。本社所在地はカリフォルニア州ア―バイン。   Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
本社所在地 70 Doppler Ivine CA 92918 USA
代表者氏名
代表者役職名
電話番号 +1 949-261-2900
設立年月日
市場名 NASDAQ Small Cap
ipoyear 2018年
従業員数
url www.hancockjaffe.com
nasdaq_url https://www.nasdaq.com/symbol/hjli
adr_tso
EBITDA EBITDA(百万ドル) -8.17638
終値(lastsale) 2.8654
時価総額(marketcap) 33574771.4778
時価総額 時価総額(百万ドル) 28.47306
売上高 売上高(百万ドル) 0.31743
企業価値(EV) 企業価値(EV)(百万ドル) 22.53064
当期純利益 当期純利益(百万ドル) -18.72681
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Hancock Jaffe Laboratories Inc revenues decreased 48% to $114K. Net loss applicable to common stockholders increased from $2.6M to $13.1M. Revenues reflect Product Sales decrease from $152K to $0K Royalty Income decrease of 10% to $60K. Higher net loss reflects Amortization of debt discount increase from $24K to $6.6M (expense) Selling/General/Admin. Expense increase of 95% to $4.2M (expense).

 HJLIのテクニカル分析


 HJLIのニュース

   Hancock Jaffe Laboratories : Receives Permission to Proceed with First-in-Human CoreoGraft Study | MarketScreener  2020/07/23 12:36:10 MarketScreener
July 23, 2020 Hancock Jaffe Receives Permission to Proceed with First-in-Human CoreoGraft Study Patient Selection to Begin Immediately for… | July 23, 2020
   Hancock Jaffe Laboratories : FY 2019 | MarketScreener  2020/03/18 22:18:13 MarketScreener
Identifying Performance Obligations and Licensing" and in May 9, 2016, the FASB issued ASU No. 2016-12, "Revenue from Contracts with Customers ", or ASU 2016-12. This update provides… | March 18, 2020
   Hancock Jaffe Laboratories : Annual report pursuant to Section 13 and 15(d) | MarketScreener  2020/03/18 21:08:23 MarketScreener
Identifying Performance Obligations and Licensing' and in May 9, 2016, the FASB issued ASU No. 2016-12, 'Revenue from Contracts with Customers ', or ASU 2016-12. This update provides clarifying… | March 18, 2020
   Hancock Jaffe Laboratories, Inc.'s (NASDAQ:HJLI) Single Biggest Risk For Investors  2019/09/19 17:32:31 Yahoo Finance
Trailing twelve-month data shows us that Hancock Jaffe Laboratories, Inc.'s (NASDAQ:HJLI) earnings loss has…
   ARCA biopharma leads healthcare gainers; Nabriva Therapeutics and Auris Medical Holding among losers  2019/05/01 15:02:18 Seeking Alpha
   Hancock Jaffe Laboratories : FY 2019 | MarketScreener  2020/03/18 22:18:13 MarketScreener
Identifying Performance Obligations and Licensing" and in May 9, 2016, the FASB issued ASU No. 2016-12, "Revenue from Contracts with Customers ", or ASU 2016-12. This update provides… | March 18, 2020
   Hancock Jaffe Laboratories : Annual report pursuant to Section 13 and 15(d) | MarketScreener  2020/03/18 21:08:23 MarketScreener
Identifying Performance Obligations and Licensing' and in May 9, 2016, the FASB issued ASU No. 2016-12, 'Revenue from Contracts with Customers ', or ASU 2016-12. This update provides clarifying… | March 18, 2020
   Hancock Jaffe Laboratories, Inc.'s (NASDAQ:HJLI) Single Biggest Risk For Investors  2019/09/19 17:32:31 Yahoo Finance
Trailing twelve-month data shows us that Hancock Jaffe Laboratories, Inc.'s (NASDAQ:HJLI) earnings loss has…
   ARCA biopharma leads healthcare gainers; Nabriva Therapeutics and Auris Medical Holding among losers  2019/05/01 15:02:18 Seeking Alpha
   Quotient and Biomerica among healthcare gainers; Alkermes and Moleculin Biotech among losers  2019/04/25 15:00:58 Seeking Alpha
   Hancock Jaffe Laboratories : FY 2019 | MarketScreener  2020/03/18 22:18:13 MarketScreener
Identifying Performance Obligations and Licensing" and in May 9, 2016, the FASB issued ASU No. 2016-12, "Revenue from Contracts with Customers ", or ASU 2016-12. This update provides… | March 18, 2020
   Hancock Jaffe Laboratories : Annual report pursuant to Section 13 and 15(d) | MarketScreener  2020/03/18 21:08:23 MarketScreener
Identifying Performance Obligations and Licensing' and in May 9, 2016, the FASB issued ASU No. 2016-12, 'Revenue from Contracts with Customers ', or ASU 2016-12. This update provides clarifying… | March 18, 2020
   Hancock Jaffe Laboratories, Inc.'s (NASDAQ:HJLI) Single Biggest Risk For Investors  2019/09/19 17:32:31 Yahoo Finance
Trailing twelve-month data shows us that Hancock Jaffe Laboratories, Inc.'s (NASDAQ:HJLI) earnings loss has…
   ARCA biopharma leads healthcare gainers; Nabriva Therapeutics and Auris Medical Holding among losers  2019/05/01 15:02:18 Seeking Alpha
   Quotient and Biomerica among healthcare gainers; Alkermes and Moleculin Biotech among losers  2019/04/25 15:00:58 Seeking Alpha

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ハンコック・ジャフィ・ラボラトリ―ズ HJLI Hancock Jaffe Laboratories Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)